Joseph Guiles
Colorado State University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph Guiles.
Tetrahedron Letters | 1991
A. I. Meyers; Michael A. Gonzalez; Vladimir Struzka; Atsushi Akahane; Joseph Guiles; Joseph S. Warmus
Abstract Use of a modified auxiliary allowed for the asymmetric synthesis of quaternary carbons adjacent to nitrogen in tetrahydroisoquinolines.
Tetrahedron Letters | 1991
A. I. Meyers; Joseph Guiles; Joseph S. Warmus; Michael A. Gonzalez
Abstract Metalation and alkylation of an optically active 1-methyl isoquinoline in the presence of an achiral formamidine leads to completely racemic material.
Biochemical Pharmacology | 1996
David G. Sawutz; Donald C. Bode; G.Maurice Briggs; John Reid; Paul C. Canniff; Lisa Caldwell; Connie R. Faltynek; Deborah Miller; Joseph A. Dunn; Lawrence de Garavilla; Joseph Guiles; Carolyn Weigelt; William F. Michne; Adi Treasurywala; Paul J. Silver
In this report, we describe the discovery and characterization of a novel biarylhydrazone series of platelet-derived growth factor (PDGF) receptor tyrosine kinase inhibitors typified by the prototype WIN 41662 (3-phenyl-N1-[1-(4-pytidyl)pyrimidine]hydrazone). WIN 41662 inhibited PDGF-stimulated autophosphorylation of PDGF receptors from human vascular smooth muscle cells (hVSMC) with an IC50 value of 60 nM. The inhibitor appeared to be competitive with respect to substrate (Mn(2+)-ATP), having a calculated Ki of 15 +/- 5 nM. WIN 41662 was approximately 500-fold more potent in inhibiting the PDGF receptor tyrosine kinase than the p56lck tyrosine kinase. It was inactive against other serine/threonine and tyrosine kinases tested. WIN 41662 produced concentration-dependent inhibition of PDGF-stimulated receptor autophosphorylation in intact hVSMC with an IC50 < 100 nM. Intracellular Ca2+ mobilization and cell proliferation were events that occurred in hVSMC subsequent to PDGF receptor activation. WIN 41662 inhibited PDGF-stimulated Ca2+ mobilization and cell proliferation ([3H]TdR incorporation) with IC50 values of 430 nM and 2.3 microM, respectively. These effects appeared to be specifically related to PDGF receptor tyrosine kinase inhibition since WIN 41662 was not cytotoxic (in vitro) and since WIN 72039, a close structural analog that does not inhibit PDGF receptor tyrosine kinase, also did not inhibit PDGF-stimulated receptor autophosphorylation, Ca2+ mobilization, or hVSMC proliferation. Thus, WIN 41662 is representative of a novel class of selective PDGF receptor tyrosine kinase inhibitors that inhibit PDGF-regulated secondary events in intact cells.
Journal of Organic Chemistry | 2008
Jian Qiu; Albert Gyorokos; Theodore M. Tarasow; Joseph Guiles
An efficient nickel-catalyzed Kumada-Corriu cross coupling enabled the introduction of an alpha-fluorovinyl functionality with excellent conversion and specificity.
Tetrahedron Letters | 1991
A. I. Meyers; Joseph S. Warmus; Michael A. Gonzalez; Joseph Guiles; Atsushi Akahane
Abstract The effect on facial selectivity and degree of stereoselectivity by varying the size of the chiral auxiliary allows a mechanism for alkylation to be presented.
Tetrahedron Letters | 1990
A. I. Meyers; Joseph Guiles
Abstract A four-step synthesis of optically pure 6α-phenyl pyrroloisoquinolines from chiral formamidines has been accomplished.
Journal of Organic Chemistry | 1996
Joseph Guiles; Sigmond G. Johnson; William V. Murray
Journal of Medicinal Chemistry | 1995
William F. Michne; Joseph Guiles; Adi Treasurywala; Laurie A. Castonguay; Carolyn Weigelt; Bernard O'Connor; Walter A. Volberg; Alison M. Grant; Christopher C. Chadwick; Douglas S. Krafte; Roger J. Hill
Archive | 2004
Nebojsa Janjic; Ian A. Critchley; Joseph Guiles; Theodore M. Tarasow
Journal of Organic Chemistry | 1991
Joseph Guiles; A. I. Meyers